| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 24.34▼ | 24.33▼ | 24.34▼ | 23.20▲ | 21.05▲ |
| MA10 | 24.21▲ | 24.37▼ | 24.37▼ | 22.70▲ | 18.31▲ |
| MA20 | 24.29▲ | 24.32▼ | 23.86▲ | 20.98▲ | 14.07▲ |
| MA50 | 24.34▼ | 23.42▲ | 23.02▲ | 18.13▲ | 8.46▲ |
| MA100 | 24.36▼ | 22.89▲ | 21.64▲ | 13.63▲ | 6.26▲ |
| MA200 | 23.86▲ | 21.41▲ | 20.12▲ | 8.63▲ | 6.74▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.018▲ | -0.075▼ | -0.017▼ | 0.207▲ | 0.993▲ |
| RSI | 51.253▲ | 55.342▲ | 61.272▲ | 67.523▲ | 76.495▲ |
| STOCH | 72.672 | 37.639 | 51.500 | 82.071▲ | 85.480▲ |
| WILL %R | -39.706 | -62.037 | -28.151 | -9.496▲ | -3.892▲ |
| CCI | 42.543 | -40.654 | 33.449 | 134.240▲ | 125.612▲ |
|
Thursday, December 04, 2025 03:13 AM
Discover Kodiak's focused pipeline and late-stage trials advancing retinal disease therapies. Learn why KOD stands out in biotech.
|
|
Monday, November 17, 2025 08:00 PM
Detailed price information for Kodiak Sciences Inc (KOD-Q) from The Globe and Mail including charting and trades.
|
|
Monday, November 17, 2025 04:07 PM
Fintel reports that on November 17, 2025, Chardan Capital maintained coverage of Kodiak Sciences (NasdaqGM:KOD) with a Neutral recommendation. As of November 17, 2025, the average one-year price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/25 | 24.60 | 24.99 | 23.90 | 24.34 | 582,995 |
| 04/12/25 | 22.65 | 24.76 | 22.50 | 24.76 | 653,070 |
| 03/12/25 | 21.96 | 23.45 | 21.51 | 22.96 | 686,035 |
| 02/12/25 | 21.87 | 23.0499 | 21.50 | 22.00 | 716,436 |
| 01/12/25 | 22.22 | 23.00 | 21.24 | 21.94 | 697,604 |
| 28/11/25 | 22.50 | 23.29 | 22.25 | 22.98 | 266,533 |
| 26/11/25 | 22.88 | 23.63 | 22.26 | 22.44 | 569,767 |
| 25/11/25 | 21.67 | 23.12 | 20.7001 | 22.99 | 812,434 |
| 24/11/25 | 20.64 | 23.00 | 20.38 | 21.87 | 892,780 |
| 21/11/25 | 19.46 | 21.9453 | 19.25 | 20.77 | 987,724 |
|
|
||||
|
|
||||
|
|